» Authors » Marcos Papais Alvarenga

Marcos Papais Alvarenga

Explore the profile of Marcos Papais Alvarenga including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 174
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Meneguette N, Almeida K, Figueiredo M, de Araujo E Araujo A, Alvarenga M, Vasconcelos C, et al.
Mult Scler Relat Disord . 2021 Sep; 56:103260. PMID: 34562767
Background: Biomarkers have improved the classification of autoimmune inflammatory disorders, including optic neuritis (ON) as a frequent presentation of multiple sclerosis, neuromyelitis spectrum disorders, MOG antibody-related disease (MOGAD), and opticospinal...
2.
Alvarenga M, do Carmo L, Vasconcelos C, Papais Alvarenga M, Alvarenga-Filho H, de Melo Bento C, et al.
Sci Rep . 2021 Jan; 11(1):152. PMID: 33420337
Neuromyelitis Optica and Multiple Sclerosis are idiopathic inflammatory demyelinating diseases of the central nervous system that currently are considered distinct autoimmune diseases, so differences in genetic susceptibility would be expected....
3.
Alvarenga R, de Araujo E Araujo A, Nascimento A, Araujo N, Meneguette N, Neri V, et al.
Mult Scler Relat Disord . 2020 May; 42:102082. PMID: 32361664
Background: A specific particularity of neurological diseases in Asia is the relative commonality of neuromyelitis optica (NMO) and Asian type MS (OSMS). Both conditions also occur in South American patients....
4.
Salvador N, Brito M, Alvarenga M, Alvarenga R
Mult Scler Relat Disord . 2019 Jun; 34:59-62. PMID: 31228717
Introduction: Since neuromyelitis optic is a disease associated with humoral immunity (Th2), it is speculated that the pregnancy period is associated with increased relapses of the disease, as well as...
5.
Cerqueira Pinto S, Vasconcelos C, Aurencao J, Alvarenga M, das Gracas Gomes Camargo S, Thuler L, et al.
Pediatr Neurol . 2019 Mar; 94:48-54. PMID: 30850228
Background: The onset of multiple sclerosis (MS) in 2% to 10% of cases occurs prior to 18 years of age. Early age onset appears to affect some aspects of multiple...
6.
da Silva Bernardes M, Antao Paiva C, Paradela E, Alvarenga M, Pereira F, Vasconcelos C, et al.
J Neuroimmunol . 2019 Mar; 330:74-80. PMID: 30836273
Background: The HLA-DR15 extended haplotype HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 comprises the strongest genetic risk factor for multiple sclerosis (MS). The aim of this work was to investigate whether HLA-DR15 alleles were significantly associated...
7.
Papais-Alvarenga R, Neri V, de Araujo E Araujo A, da Silva E, Alvarenga M, Pereira A, et al.
Mult Scler Relat Disord . 2018 Jul; 25:87-94. PMID: 30056361
Objective: Antibodies against Myelin Oligodendrocyte glycoprotein (MOG-Ab) have been investigated as potential biological marker for neuromyelitis optica (NMO) and high-risk syndromes (HR) negative for AQP4-Ab in populations with different ethnic...
8.
Vasconcelos C, Aurencao J, Thuler L, Camargo S, Alvarenga M, Alvarenga R
Mult Scler Relat Disord . 2016 Jul; 8:27-34. PMID: 27456871
Background: Predicting the long-term prognosis of patients with multiple sclerosis (MS) remains an uncertain and difficult task, with most data having been obtained exclusively from Caucasian cohorts. Objective: To investigate...
9.
Papais-Alvarenga R, Vasconcelos C, Carra A, Soto de Castillo I, Florentin S, de Bedoya F, et al.
PLoS One . 2015 Jul; 10(7):e0127757. PMID: 26222205
The idiopathic inflammatory demyelinating disease (IIDD) spectrum has been investigated among different populations, and the results have indicated a low relative frequency of neuromyelitis optica (NMO) among multiple sclerosis (MS)...
10.
Papais Alvarenga M, Alvarenga R, Alvarenga M, Santos A, Thuler L
J Spinal Cord Med . 2012 Aug; 35(4):251-5. PMID: 22925751
Background: The anti-aquaporin4 (anti-AQP4) antibody is specific for neuromyelitis optica (NMO), but is also found in limited forms. The presence of this antibody in acute transverse myelitis (ATM) has been...